标题
Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 18, Issue 7, Pages 1338
出版商
MDPI AG
发表日期
2017-06-22
DOI
10.3390/ijms18071338
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Preclinical Rationale for the Phase III Trials in Metastatic Pancreatic Cancer
- (2017) Ramya Thota et al. PANCREAS
- 747TiPSCHEDULING NAB-PACLITAXEL WITH GEMCITABINE (SIEGE): RANDOMISED PHASE II TRIAL TO INVESTIGATE TWO DIFFERENT SCHEDULES OF NAB-PACLITAXEL (ABX) COMBINED WITH GEMCITABINE (GEM) AS FIRST LINE TREATMENT FOR METASTATIC PANCREATIC ADENOCARCINOMA (PDAC)
- (2017) P. Corrie et al. ANNALS OF ONCOLOGY
- Tolerability and efficacy of modified FOLFIRINOX (mFOLFIRINOX) in patients with borderline-resectable pancreatic cancer (BRPC) and locally advanced unresectable pancreatic cancer (LAURPC).
- (2017) Marlo A. Blazer et al. JOURNAL OF CLINICAL ONCOLOGY
- Pancreatic cancer: Current research and future directions
- (2016) Marco Falasca et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- DocOx (AIO-PK0106): a phase II trial of docetaxel and oxaliplatin as a second line systemic therapy in patients with advanced pancreatic ductal adenocarcinoma
- (2016) Thomas J. Ettrich et al. BMC CANCER
- Phase Ib Study of PEGylated Recombinant Human Hyaluronidase and Gemcitabine in Patients with Advanced Pancreatic Cancer
- (2016) S. R. Hingorani et al. CLINICAL CANCER RESEARCH
- The role of neoadjuvant therapy in pancreatic cancer: a review
- (2016) Suzanne Russo et al. Future Oncology
- Myeloid cells are required for PD-1/PD-L1 checkpoint activation and the establishment of an immunosuppressive environment in pancreatic cancer
- (2016) Yaqing Zhang et al. GUT
- MicroRNA Targeted Therapeutic Approach for Pancreatic Cancer
- (2016) Yiwei Li et al. International Journal of Biological Sciences
- Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib
- (2016) Pascal Hammel et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Results of the phase Ib portion of a phase I/II trial of the indoleamine 2,3-dioxygenase pathway (IDO) inhibitor indoximod plus gemcitabine/nab-paclitaxel for the treatment of metastatic pancreatic cancer.
- (2016) Nathan Bahary et al. JOURNAL OF CLINICAL ONCOLOGY
- PANCREOX: A Randomized Phase III Study of Fluorouracil/Leucovorin With or Without Oxaliplatin for Second-Line Advanced Pancreatic Cancer in Patients Who Have Received Gemcitabine-Based Chemotherapy
- (2016) Sharlene Gill et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)
- (2016) Katsuhiko Uesaka et al. LANCET
- Genomic analyses identify molecular subtypes of pancreatic cancer
- (2016) Peter Bailey et al. NATURE
- Nab-paclitaxel plus gemcitabine as first-line palliative chemotherapy in a patient with metastatic pancreatic cancer with Eastern Cooperative Oncology Group performance status of 2
- (2016) ANDRÉS J. MUÑOZ MARTÍN et al. Oncology Letters
- Pancreatic Cancer from Molecular Pathways to Treatment Opinion
- (2016) Michail Karanikas et al. Journal of Cancer
- A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer
- (2015) B. H. O'Neil et al. ANNALS OF ONCOLOGY
- A phase 3 randomized, double-blind, placebo-controlled trial of ganitumab or placebo in combination with gemcitabine as first-line therapy for metastatic adenocarcinoma of the pancreas: the GAMMA trial†
- (2015) C. S. Fuchs et al. ANNALS OF ONCOLOGY
- Recent advances in pancreatic cancer: biology, treatment, and prevention
- (2015) Divya Singh et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Phase II study of capecitabine and the oral mTOR inhibitor everolimus in patients with advanced pancreatic cancer
- (2015) S. Kordes et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase II study of lapatinib and capecitabine in second-line treatment for metastatic pancreatic cancer
- (2015) Zheng Wu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Precision Medicine for Advanced Pancreas Cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) Trial
- (2015) L. A. Chantrill et al. CLINICAL CANCER RESEARCH
- Treatment of patients with metastatic pancreatic cancer: Experience from a tertiary Indian cancer center
- (2015) B Sirohi et al. INDIAN JOURNAL OF CANCER
- Efficacy and safety of axitinib in combination with gemcitabine in advanced pancreatic cancer: subgroup analyses by region, including Japan, from the global randomized Phase III trial
- (2015) T. Ioka et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Gemcitabine and S-1 combination chemotherapy versus gemcitabine alone for locally advanced and metastatic pancreatic cancer: a meta-analysis of randomized controlled trials in Asia
- (2015) Yanxun Li et al. JOURNAL OF CHEMOTHERAPY
- Final results of a phase Ib study of gemcitabine plus PEGPH20 in patients with stage IV previously untreated pancreatic cancer.
- (2015) Sunil R. Hingorani et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed
- (2015) Herbert I. Hurwitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer
- (2015) Daniel V.T. Catenacci et al. JOURNAL OF CLINICAL ONCOLOGY
- Olaparib Monotherapy in Patients With Advanced Cancer and a GermlineBRCA1/2Mutation
- (2015) Bella Kaufman et al. JOURNAL OF CLINICAL ONCOLOGY
- Neoadjuvant modified FOLFIRINOX and chemoradiation therapy for locally advanced pancreatic cancer improves resectability
- (2015) Ronica H. Nanda et al. JOURNAL OF SURGICAL ONCOLOGY
- nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial
- (2015) D. Goldstein et al. JNCI-Journal of the National Cancer Institute
- Pancreatic cancer: from state-of-the-art treatments to promising novel therapies
- (2015) Ignacio Garrido-Laguna et al. Nature Reviews Clinical Oncology
- The Role of Nutraceuticals in Pancreatic Cancer Prevention and Therapy
- (2015) Yiwei Li et al. PANCREAS
- Antisense inhibition of microRNA-21 and microRNA-221 in tumor-initiating stem-like cells modulates tumorigenesis, metastasis, and chemotherapy resistance in pancreatic cancer
- (2015) Yue Zhao et al. Targeted Oncology
- Novel directions in neoadjuvant therapy for pancreas adenocarcinoma
- (2015) Andrew Yang et al. Expert Review of Gastroenterology & Hepatology
- nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial
- (2015) D. Goldstein et al. JNCI-Journal of the National Cancer Institute
- Treatment of patients with metastatic pancreatic cancer: Experience from a tertiary Indian cancer center
- (2015) B Sirohi et al. INDIAN JOURNAL OF CANCER
- MEK and PI3K inhibition in solid tumors: rationale and evidence to date
- (2015) E. Jokinen et al. Therapeutic Advances in Medical Oncology
- O-0003 * NAPOLI-1: RANDOMIZED PHASE 3 STUDY OF MM-398 (NAL-IRI), WITH OR WITHOUT 5-FLUOROURACIL AND LEUCOVORIN, VERSUS 5-FLUOROURACIL AND LEUCOVORIN, IN METASTATIC PANCREATIC CANCER PROGRESSED ON OR FOLLOWING GEMCITABINE-BASED THERAPY
- (2014) D. Von Hoff et al. ANNALS OF ONCOLOGY
- Second-Line Capecitabine and Oxaliplatin Combination for Gemcitabine-Resistant Advanced Pancreatic Cancer
- (2014) Ibrahim Vedat Bayoglu et al. Asian Pacific Journal of Cancer Prevention
- Efficacy of gemcitabine conjugated and miRNA-205 complexed micelles for treatment of advanced pancreatic cancer
- (2014) Anupama Mittal et al. BIOMATERIALS
- FOLFOX as second-line chemotherapy in patients with pretreated metastatic pancreatic cancer from the FIRGEM study
- (2014) Aziz Zaanan et al. BMC CANCER
- Oncogenic KRAS signalling in pancreatic cancer
- (2014) S Eser et al. BRITISH JOURNAL OF CANCER
- Dual blockade of epidermal growth factor receptor and insulin-like growth factor receptor-1 signaling in metastatic pancreatic cancer: Phase Ib and randomized phase II trial of gemcitabine, erlotinib, and cixutumumab versus gemcitabine plus erlotinib (SWO
- (2014) Philip A. Philip et al. CANCER
- Genistein Inhibits Cell Growth and Invasion Through Regulation of miR-27a in Pancreatic Cancer Cells
- (2014) Jun Xia et al. CURRENT PHARMACEUTICAL DESIGN
- A randomised, double-blind, placebo-controlled trial of trametinib, an oral MEK inhibitor, in combination with gemcitabine for patients with untreated metastatic adenocarcinoma of the pancreas
- (2014) Jeffrey R. Infante et al. EUROPEAN JOURNAL OF CANCER
- A phase II study of the gamma secretase inhibitor RO4929097 in patients with previously treated metastatic pancreatic adenocarcinoma
- (2014) Ana De Jesus-Acosta et al. INVESTIGATIONAL NEW DRUGS
- Second-Line Oxaliplatin, Folinic Acid, and Fluorouracil Versus Folinic Acid and Fluorouracil Alone for Gemcitabine-Refractory Pancreatic Cancer: Outcomes From the CONKO-003 Trial
- (2014) Helmut Oettle et al. JOURNAL OF CLINICAL ONCOLOGY
- Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial
- (2014) Gary Middleton et al. LANCET ONCOLOGY
- Neoadjuvant FOLFIRINOX for Borderline Resectable Pancreas Cancer: A New Treatment Paradigm?
- (2014) K. K. Christians et al. ONCOLOGIST
- Evidence for the Importance of Personalized Molecular Profiling in Pancreatic Cancer
- (2014) Loukia N. Lili et al. PANCREAS
- Expression of MicroRNA-15b and the Glycosyltransferase GCNT3 Correlates with Antitumor Efficacy of Rosemary Diterpenes in Colon and Pancreatic Cancer
- (2014) Margarita González-Vallinas et al. PLoS One
- Deep Sequencing of RNA from Three Different Extracellular Vesicle (EV) Subtypes Released from the Human LIM1863 Colon Cancer Cell Line Uncovers Distinct Mirna-Enrichment Signatures
- (2014) Hong Ji et al. PLoS One
- Alteration of the microRNA expression profile during the activation of pancreatic stellate cells
- (2014) Atsushi Masamune et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Pancreatic cancer and its stroma: A conspiracy theory
- (2014) Zhihong Xu WORLD JOURNAL OF GASTROENTEROLOGY
- S-1 in the treatment of pancreatic cancer
- (2014) Kentaro Sudo WORLD JOURNAL OF GASTROENTEROLOGY
- Borderline resectable pancreatic cancer: Definitions and management
- (2014) Nicole E Lopez WORLD JOURNAL OF GASTROENTEROLOGY
- Neoadjuvant Therapy in Pancreatic Cancer: An Emerging Strategy
- (2014) Alessandro Bittoni et al. Gastroenterology Research and Practice
- MicroRNA expression profiling of diagnostic needle aspirates from surgical pancreatic cancer specimens
- (2014) Tae Ho Hong et al. Annals of Surgical Treatment and Research
- Endoscopically Acquired Pancreatic Cyst Fluid MicroRNA 21 and 221 Are Associated With Invasive Cancer
- (2013) James J Farrell et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Neoadjuvant Chemotherapy with Gemcitabine and S-1 for Resectable and Borderline Pancreatic Ductal Adenocarcinoma: Results from a Prospective Multi-institutional Phase 2 Trial
- (2013) Fuyuhiko Motoi et al. ANNALS OF SURGICAL ONCOLOGY
- Cationic microRNA-delivering nanovectors with bifunctional peptides for efficient treatment of PANC-1 xenograft model
- (2013) Q.L. Hu et al. BIOMATERIALS
- Clinical impact of circulating miR-221 in plasma of patients with pancreatic cancer
- (2013) T Kawaguchi et al. BRITISH JOURNAL OF CANCER
- A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer
- (2013) Edward J. Kim et al. CANCER
- CD40 immunotherapy for pancreatic cancer
- (2013) Robert H. Vonderheide et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Adjuvant therapy for resectable pancreatic adenocarcinoma: Review of the current treatment approaches and future directions
- (2013) G. Antoniou et al. CANCER TREATMENT REVIEWS
- Resveratrol induces apoptosis of pancreatic cancers cells by inhibiting miR-21 regulation of BCL-2 expression
- (2013) P. Liu et al. Clinical & Translational Oncology
- MicroRNA-34b Inhibits Pancreatic Cancer Metastasis Through Repressing Smad3
- (2013) C. Liu et al. CURRENT MOLECULAR MEDICINE
- Treatment of Borderline Resectable Pancreatic Cancer
- (2013) Amanda B. Cooper et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Randomised, placebo-controlled, double-blind, parallel-group phase III study evaluating aflibercept in patients receiving first-line treatment with gemcitabine for metastatic pancreatic cancer
- (2013) Philippe Rougier et al. EUROPEAN JOURNAL OF CANCER
- Stereotactic Body Radiation Therapy for Locally Advanced and Borderline Resectable Pancreatic Cancer Is Effective and Well Tolerated
- (2013) Michael D. Chuong et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- A multicenter phase II trial of gemcitabine and candesartan combination therapy in patients with advanced pancreatic cancer: GECA2
- (2013) Yousuke Nakai et al. INVESTIGATIONAL NEW DRUGS
- Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer
- (2013) Helmut Oettle et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of chemoradiotherapy and neoadjuvant chemoradiotherapy in resectable pancreatic cancer: a systematic review and meta-analysis
- (2013) C. P. Xu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Randomized, Multicenter, Phase II Study of CO-101 Versus Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma: Including a Prospective Evaluation of the Role of hENT1 in Gemcitabine or CO-101 Sensitivity
- (2013) Elizabeth Poplin et al. JOURNAL OF CLINICAL ONCOLOGY
- MLH1 as a Direct Target of MiR-155 and a Potential Predictor of Favorable Prognosis in Pancreatic Cancer
- (2013) Wen-Jing Liu et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Radiographic Tumor–Vein Interface as a Predictor of Intraoperative, Pathologic, and Oncologic Outcomes in Resectable and Borderline Resectable Pancreatic Cancer
- (2013) Hop S. Tran Cao et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Influence of preoperative anti-cancer therapy on resectability and perioperative outcomes in patients with pancreatic cancer: Project study by the Japanese Society of Hepato-Biliary-Pancreatic Surgery
- (2013) Fuyuhiko Motoi et al. Journal of Hepato-Biliary-Pancreatic Sciences
- Evaluation of Ipilimumab in Combination With Allogeneic Pancreatic Tumor Cells Transfected With a GM-CSF Gene in Previously Treated Pancreatic Cancer
- (2013) Dung T. Le et al. JOURNAL OF IMMUNOTHERAPY
- Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial
- (2013) Somnath Mukherjee et al. LANCET ONCOLOGY
- Targeting miR-21 for the Therapy of Pancreatic Cancer
- (2013) Flavie Sicard et al. MOLECULAR THERAPY
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evolution and dynamics of pancreatic cancer progression
- (2013) S Yachida et al. ONCOGENE
- Regulation of miR-155 affects pancreatic cancer cell invasiveness and migration by modulating the STAT3 signaling pathway through SOCS1
- (2013) CHEN HUANG et al. ONCOLOGY REPORTS
- Modified FOLFIRINOX Regimen With Improved Safety and Maintained Efficacy in Pancreatic Adenocarcinoma
- (2013) Hemchandra Mahaseth et al. PANCREAS
- MicroRNA-21 in Pancreatic Ductal Adenocarcinoma Tumor-Associated Fibroblasts Promotes Metastasis
- (2013) Brian E. Kadera et al. PLoS One
- CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancer
- (2013) A. Neesse et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- How to Define and Manage Borderline Resectable Pancreatic Cancer
- (2013) Pavlos Papavasiliou et al. SURGICAL CLINICS OF NORTH AMERICA
- Efficacy of nimotuzumab plus gemcitabine usage as first-line treatment in patients with advanced pancreatic cancer
- (2013) Dan Su et al. TUMOR BIOLOGY
- Neoadjuvant Therapy and Vascular Resection During Pancreaticoduodenectomy: Shifting the Survival Curve for Patients with Locally Advanced Pancreatic Cancer
- (2013) Irene Epelboym et al. WORLD JOURNAL OF SURGERY
- Emerging concepts in pancreatic cancer medicine: targeting the tumor stroma
- (2013) Albrecht Neesse et al. OncoTargets and Therapy
- Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
- (2013) Vikash P. Chauhan et al. Nature Communications
- Progress of Molecular Targeted Therapies for Advanced Renal Cell Carcinoma
- (2013) Alessandro Conti et al. Biomed Research International
- Everolimus in the treatment of patients with advanced pancreatic neuroendocrine tumors: latest findings and interpretations
- (2013) Eric Liu et al. Therapeutic Advances in Gastroenterology
- BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer
- (2012) A. Gonçalves et al. ANNALS OF ONCOLOGY
- Targeting Phosphoinositide 3-Kinase Pathways in Pancreatic Cancer – from Molecular Signalling to Clinical Trials
- (2012) Marco Falasca et al. Anti-Cancer Agents in Medicinal Chemistry
- Pancreatic stellate cells enhance stem cell-like phenotypes in pancreatic cancer cells
- (2012) Shin Hamada et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma
- (2012) Peter J Hosein et al. BMC CANCER
- Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer
- (2012) J Harder et al. BRITISH JOURNAL OF CANCER
- Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators
- (2012) Matthew H. G. Katz et al. CANCER
- FOLFIRI as second-line chemotherapy for advanced pancreatic cancer: a GISCAD multicenter phase II study
- (2012) Alberto Zaniboni et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Anti-DLL4 Has Broad Spectrum Activity in Pancreatic Cancer Dependent on Targeting DLL4-Notch Signaling in Both Tumor and Vasculature Cells
- (2012) W.-C. Yen et al. CLINICAL CANCER RESEARCH
- The Pancreas Cancer Microenvironment
- (2012) C. Feig et al. CLINICAL CANCER RESEARCH
- Genistein Inhibits Cell Growth and Induces Apoptosis Through Up-regulation of miR-34a in Pancreatic Cancer Cells
- (2012) Jun Xia et al. CURRENT DRUG TARGETS
- Impact of FOLFIRINOX Compared With Gemcitabine on Quality of Life in Patients With Metastatic Pancreatic Cancer: Results From the PRODIGE 4/ACCORD 11 Randomized Trial
- (2012) Sophie Gourgou-Bourgade et al. JOURNAL OF CLINICAL ONCOLOGY
- Pathological and clinical impact of neoadjuvant chemoradiotherapy using full-dose gemcitabine and concurrent radiation for resectable pancreatic cancer
- (2012) Masayuki Sho et al. Journal of Hepato-Biliary-Pancreatic Sciences
- MicroRNA expression profiles associated with pancreatic adenocarcinoma and ampullary adenocarcinoma
- (2012) Nicolai A Schultz et al. MODERN PATHOLOGY
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Expression of MicroRNAs in Patients With Pancreatic Cancer and Its Prognostic Significance
- (2012) Ioannis G. Papaconstantinou et al. PANCREAS
- MicroRNAs Targeting Oncogenes Are Down-Regulated in Pancreatic Malignant Transformation from Benign Tumors
- (2012) Long R. Jiao et al. PLoS One
- Prospective efficacy and safety study of neoadjuvant gemcitabine with capecitabine combination chemotherapy for borderline-resectable or unresectable locally advanced pancreatic adenocarcinoma
- (2012) Jae-Lyun Lee et al. SURGERY
- FOLFIRI regimen in metastatic pancreatic adenocarcinoma resistant to gemcitabine and platinum-salts
- (2012) Cindy Neuzillet WORLD JOURNAL OF GASTROENTEROLOGY
- Advanced age is a risk factor for post-operative complications and mortality after a pancreaticoduodenectomy: a meta-analysis and systematic review
- (2012) Sukharamwala Prashant et al. HPB
- Pilot study of neoadjuvant chemotherapy with gemcitabine and oral S-1 for resectable pancreatic cancer
- (2012) HIDEHIRO TAJIMA et al. Experimental and Therapeutic Medicine
- nab -Paclitaxel Potentiates Gemcitabine Activity by Reducing Cytidine Deaminase Levels in a Mouse Model of Pancreatic Cancer
- (2012) Kristopher K. Frese et al. Cancer Discovery
- Immunotherapy updates in pancreatic cancer: are we there yet?
- (2012) Krishna Soujanya Gunturu et al. Therapeutic Advances in Medical Oncology
- Fluorouracil-based Chemoradiation with Either Gemcitabine or Fluorouracil Chemotherapy after Resection of Pancreatic Adenocarcinoma: 5-Year Analysis of the U.S. Intergroup/RTOG 9704 Phase III Trial
- (2011) William F. Regine et al. ANNALS OF SURGICAL ONCOLOGY
- Preoperative Capecitabine and Concurrent Radiation for Borderline Resectable Pancreatic Cancer
- (2011) Jayme B. Stokes et al. ANNALS OF SURGICAL ONCOLOGY
- MicroRNA-21: A novel therapeutic target in human cancer
- (2011) Xuan Pan et al. CANCER BIOLOGY & THERAPY
- Curcumin Analogue CDF Inhibits Pancreatic Tumor Growth by Switching on Suppressor microRNAs and Attenuating EZH2 Expression
- (2011) B. Bao et al. CANCER RESEARCH
- MicroRNA Molecular Profiles Associated with Diagnosis, Clinicopathologic Criteria, and Overall Survival in Patients with Resectable Pancreatic Ductal Adenocarcinoma
- (2011) N. B. Jamieson et al. CLINICAL CANCER RESEARCH
- MicroRNA Alterations of Pancreatic Intraepithelial Neoplasias
- (2011) J. Yu et al. CLINICAL CANCER RESEARCH
- Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: A phase III-study from the German CONKO-study group
- (2011) Uwe Pelzer et al. EUROPEAN JOURNAL OF CANCER
- A phase II open-label randomized study to assess the efficacy and safety of selumetinib (AZD6244 [ARRY-142886]) versus capecitabine in patients with advanced or metastatic pancreatic cancer who have failed first-line gemcitabine therapy
- (2011) György Bodoky et al. INVESTIGATIONAL NEW DRUGS
- Inactivation of Ink4a/Arf leads to deregulated expression of miRNAs in K-Ras transgenic mouse model of pancreatic cancer
- (2011) Shadan Ali et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma
- (2011) Hideaki Ijichi et al. JOURNAL OF CLINICAL INVESTIGATION
- Neo-adjuvant Chemoradiation Therapy Using S-1 Followed by Surgical Resection in Patients with Pancreatic Cancer
- (2011) Sohei Satoi et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Potential Contribution of Preoperative Neoadjuvant Concurrent Chemoradiation Therapy on Margin-Negative Resection in Borderline Resectable Pancreatic Cancer
- (2011) Chang Moo Kang et al. JOURNAL OF GASTROINTESTINAL SURGERY
- A Decision Model of Therapy for Potentially Resectable Pancreatic Cancer
- (2011) Jacob P. VanHouten et al. JOURNAL OF SURGICAL RESEARCH
- Pancreatic cancer
- (2011) Audrey Vincent et al. LANCET
- Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study
- (2011) Hedy L Kindler et al. LANCET ONCOLOGY
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting Epigenetic Regulation of miR-34a for Treatment of Pancreatic Cancer by Inhibition of Pancreatic Cancer Stem Cells
- (2011) Dara Nalls et al. PLoS One
- CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
- (2011) G. L. Beatty et al. SCIENCE
- Lapatinib and Gemcitabine for Metastatic Pancreatic Cancer
- (2010) Howard Safran et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Distal Pancreatectomy Combined with Celiac Axis Resection in Treatment of Carcinoma of the Body/Tail of the Pancreas: A Single-Center Experience
- (2010) Xubo Wu et al. ANNALS OF SURGICAL ONCOLOGY
- Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies
- (2010) Milind M Javle et al. BMC CANCER
- Inhibition of renin–angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine
- (2010) Y Nakai et al. BRITISH JOURNAL OF CANCER
- MicroRNA-21 in Pancreatic Cancer: Correlation with Clinical Outcome and Pharmacologic Aspects Underlying Its Role in the Modulation of Gemcitabine Activity
- (2010) Elisa Giovannetti et al. CANCER RESEARCH
- miR-146a Suppresses Invasion of Pancreatic Cancer Cells
- (2010) Y. Li et al. CANCER RESEARCH
- Gemcitabine plus sorafenib in patients with advanced pancreatic cancer: a phase II trial of the University of Chicago Phase II Consortium
- (2010) Hedy Lee Kindler et al. INVESTIGATIONAL NEW DRUGS
- Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection
- (2010) John P. Neoptolemos et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205
- (2010) Philip A. Philip et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized phase II study of gemcitabine plus radiotherapy versus gemcitabine, 5-fluorouracil, and cisplatin followed by radiotherapy and 5-fluorouracil for patients with locally advanced, potentially resectable pancreatic adenocarcinoma
- (2010) Jerome Landry et al. JOURNAL OF SURGICAL ONCOLOGY
- Metastatic pancreatic cancer: Is gemcitabine still the best standard treatment? (Review)
- (2010) Di Marco ONCOLOGY REPORTS
- Aberrant MicroRNA-155 Expression Is an Early Event in the Multistep Progression of Pancreatic Adenocarcinoma
- (2010) Ji Kon Ryu et al. PANCREATOLOGY
- NeoGemOx: Gemcitabine and oxaliplatin as neoadjuvant treatment for locally advanced, nonmetastasized pancreatic cancer
- (2010) Klaus Sahora et al. SURGERY
- Management of Borderline Resectable Pancreatic Cancer
- (2010) Alysandra Lal et al. Surgical Oncology Clinics of North America
- Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages
- (2010) Sonja Gillen et al. PLOS MEDICINE
- Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement
- (2009) Mark P. Callery et al. ANNALS OF SURGICAL ONCOLOGY
- Arterial and Venous Resection for Pancreatic Adenocarcinoma
- (2009) Robert C. G. Martin ARCHIVES OF SURGERY
- Outcome of upfront combination chemotherapy followed by chemoradiation for locally advanced pancreatic adenocarcinoma
- (2009) Michele Reni et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Up-regulation of miR-200 and let-7 by Natural Agents Leads to the Reversal of Epithelial-to-Mesenchymal Transition in Gemcitabine-Resistant Pancreatic Cancer Cells
- (2009) Y. Li et al. CANCER RESEARCH
- Acquisition of Epithelial-Mesenchymal Transition Phenotype of Gemcitabine-Resistant Pancreatic Cancer Cells Is Linked with Activation of the Notch Signaling Pathway
- (2009) Z. Wang et al. CANCER RESEARCH
- Ligand-dependent Notch Signaling Is Involved in Tumor Initiation and Tumor Maintenance in Pancreatic Cancer
- (2009) M. E. Mullendore et al. CLINICAL CANCER RESEARCH
- Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival
- (2009) Thomas Greither et al. INTERNATIONAL JOURNAL OF CANCER
- Phase III Trial of Bevacizumab in Combination With Gemcitabine and Erlotinib in Patients With Metastatic Pancreatic Cancer
- (2009) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer
- (2009) David Cunningham et al. JOURNAL OF CLINICAL ONCOLOGY
- Can preoperative CA19-9 and CEA levels predict the resectability of patients with pancreatic adenocarcinoma?
- (2009) Young Choon Kim et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance
- (2009) T. Moriyama et al. MOLECULAR CANCER THERAPEUTICS
- Approval Summary: Imatinib Mesylate in the Treatment of Metastatic and/or Unresectable Malignant Gastrointestinal Stromal Tumors
- (2009) M. H. Cohen et al. ONCOLOGIST
- MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cells
- (2009) Qing Ji et al. PLoS One
- Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
- (2009) K. P. Olive et al. SCIENCE
- The Janus faces of CD40 in cancer
- (2009) Angelica S.I. Loskog et al. SEMINARS IN IMMUNOLOGY
- Molecular targeted therapies for pancreatic cancer
- (2008) Daniel Borja-Cacho et al. AMERICAN JOURNAL OF SURGERY
- Neoadjuvant Chemotherapy Generates a Significant Tumor Response in Resectable Pancreatic Cancer Without Increasing Morbidity
- (2008) Stefan Heinrich et al. ANNALS OF SURGERY
- Pancreatic Cancer
- (2008) Anirban Maitra et al. Annual Review of Pathology-Mechanisms of Disease
- Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer
- (2008) Volker Heinemann et al. BMC CANCER
- Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer: results of secondary end points analyses
- (2008) A Sultana et al. BRITISH JOURNAL OF CANCER
- Tumor-Node-Metastasis Staging of Pancreatic Adenocarcinoma
- (2008) M. H. G. Katz et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Gemcitabine Combined with Gefitinib in Patients with Inoperable or Metastatic Pancreatic Cancer: A Phase II Study of the Hellenic Cooperative Oncology Group with Biomarker Evaluation
- (2008) George Fountzilas et al. CANCER INVESTIGATION
- Sonic Hedgehog Promotes Desmoplasia in Pancreatic Cancer
- (2008) J. M. Bailey et al. CLINICAL CANCER RESEARCH
- Neoadjuvant Radiation Is Associated With Improved Survival in Patients With Resectable Pancreatic Cancer: An Analysis of Data From the Surveillance, Epidemiology, and End Results (SEER) Registry
- (2008) Alexander M. Stessin et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic Head
- (2008) Gauri R. Varadhachary et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective Phase II Trial of Neoadjuvant Chemotherapy With Gemcitabine and Cisplatin for Resectable Adenocarcinoma of the Pancreatic Head
- (2008) Stefan Heinrich et al. JOURNAL OF CLINICAL ONCOLOGY
- Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic Head
- (2008) Douglas B. Evans et al. JOURNAL OF CLINICAL ONCOLOGY
- Oral mTOR Inhibitor Everolimus in Patients With Gemcitabine-Refractory Metastatic Pancreatic Cancer
- (2008) Brian M. Wolpin et al. JOURNAL OF CLINICAL ONCOLOGY
- MicroRNA-21 is Overexpressed in Pancreatic Cancer and a Potential Predictor of Survival
- (2008) Mary Dillhoff et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Effect of Neoadjuvant Therapy on Local Recurrence after Resection of Pancreatic Adenocarcinoma
- (2008) Sarah E. Greer et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Borderline Resectable Pancreatic Cancer: The Importance of This Emerging Stage of Disease
- (2008) Matthew H.G. Katz et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
- (2008) S. Jones et al. SCIENCE
- Profiling of 95 MicroRNAs in Pancreatic Cancer Cell Lines and Surgical Specimens by Real-Time PCR Analysis
- (2008) Yuqing Zhang et al. WORLD JOURNAL OF SURGERY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now